Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Med Oncol. 2024 Jul 11;41(8):200. doi: 10.1007/s12032-024-02403-8.
ABSTRACT
Cancer is one of the leading causes of death worldwide, with over 10 million fatalities annually. While tumors can be surgically removed and treated with chemotherapy, radiotherapy, immunotherapy, hormonal therapy, or combined therapies, current treatments often result in toxic side effects in normal tissue. Therefore, researchers are actively seeking ways to selectively eliminate cancerous cells, minimizing the toxic side effects in normal tissue. Caseins and its derivatives have shown promising anti-cancer potential, demonstrating antitumor and cytotoxic effects on cells from various tumor types without causing harm to normal cells. Collectively, these data reveals advancements in the study of caseins and their derivative peptides, particularly providing a comprehensive understanding of the molecular mechanism of action in cancer therapy. These mechanisms occur through various signaling pathways, including (i) the increase of interferon-associated STAT1 signaling, (ii) the suppression of stemness-related markers such as CD44, (iii) the attenuation of the STAT3/HIF1-α signaling, (iv) the down-expression of uPAR and PAI-1, (v) the loss of mitochondrial membrane potential and reduced intracellular ATP production, (vi) the increase of caspase-3 activity, and (vii) the suppression of TLR4/NF-кB signaling. Therefore, we conclude that casein could be an effective adjuvant for cancer treatment.
PMID:38990440 | DOI:10.1007/s12032-024-02403-8
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment In-vitro study of cytotoxic and apoptotic potential of Thalassia hemprichii (Ehren.) Asch. And Enhalus acoroides (L.f.) Royle against human breast cancer cell line (MCF-7) with correlation to their chemical profile In-vitro study of cytotoxic and apoptotic potential of Thalassia hemprichii (Ehren.) Asch. And Enhalus acoroides (L.f.) Royle against human breast cancer cell line (MCF-7) with correlation to their chemical profile Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma model ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model Effects of Lomerizine and Its Metabolite on Glioblastoma Cells Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells Softening the tumor matrix through cholesterol depletion breaks the physical barrier for enhanced antitumor therapy Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade Novel Tetracyclic Azaphenothiazines with the Quinoline Ring as New Anticancer and Antibacterial Derivatives of Chlorpromazine Mesenchymal stem cells as therapeutic vehicles for glioma BCKDK Modification Enhances the Anticancer Efficacy of CAR-T Cells by Reprogramming Branched Chain Amino Acid Metabolism Protective Effect of Boric Acid Against Ochratoxin A-Induced Toxic Effects in Human Embryonal Kidney Cells (HEK293): A Study on Cytotoxic, Genotoxic, Oxidative, and Apoptotic Effects Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration Pacidusin B isolated from Phyllanthus acidus triggers ferroptotic cell death in HT1080 cells Protective effects of silymarin in glioblastoma cancer cells through redox system regulation The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance The potential of methioninase for cancer treatment Induction of the DNA-Repair Gene POLQ only in BRCA1-mutant Breast-Cancer Cells by Methionine Restriction Fast Track Adaptation of Oncolytic Coxsackie B3 Virus to Resistant Colorectal Cancer Cells - a Method to Personalize Virotherapy Bone Marrow Adipose Tissue Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/b-catenin pathway and acts as an onco-immunological biomarker Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway The microtubule targeting agent ST-401 triggers cell death in interphase and prevents the formation of polyploid giant cancer cells Mechanism of inflammatory response and therapeutic effects of stem cells in ischemic stroke: current evidence and future perspectives Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies Overexpression of an Engineered SerpinB9 Enhances Allogeneic T-Cell Persistence and Efficacy Localized Sustained Release of Copper Enhances Antitumor Effects of Disulfiram in Head and Neck Cancer Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment D-CRSE: Diminishing chemotherapy-related side effects through patient education, a mixed-methods pilot study D-CRSE: Diminishing chemotherapy-related side effects through patient education, a mixed-methods pilot study Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3 Mesenchymal stem cells for cartilage regeneration: Insights into molecular mechanism and therapeutic strategies The current state and future perspectives of radiotherapy for cervical cancer Myeloid derived suppressor cells and macrophages in regulation of immune response in cancer and tumor progression BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases Enhanced cellular therapy: revolutionizing adoptive cellular therapy Critical role of the gut microbiota in immune responses and cancer immunotherapy Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis In situ brain tumor detection using a Raman spectroscopy system-results of a multicenter study Immunotherapy with an antibody against CD1d modulates neuroinflammation in an a-synuclein transgenic model of Lewy body like disease A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations Differential Cytokine Responses of APOE3 and APOE4 Blood-brain Barrier Cell Types to SARS-CoV-2 Spike Proteins From bedside to bench: New insights in epilepsy-associated tumors based on recent classification updates and animal models on brain tumor networks Dabrafenib Alleviates Hepatotoxicity Caused by Lenvatinib via Inhibiting the Death Receptor Signaling Pathway Recurrent choroid plexus carcinoma treated with CyberKnife radiosurgery: illustrative case Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy Detection of circulating tumor cells by means of machine learning using Smart-Seq2 sequencing A data-driven approach to improve wellness and reduce recurrence in cancer survivors
Evidence Blueprint
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer Autophagy Inhibition with Chloroquine Increased Pro-Apoptotic Potential of New Aziridine-Hydrazide Hydrazone Derivatives against Glioblastoma Cells Roles of Mesenchymal Stem Cells in Breast Cancer Therapy: Engineered Stem Cells and Exosomal Cell-Free Based Therapy Synthetic Derivatives of Natural ent-Kaurane Atractyligenin Disclose Anticancer Properties in Colon Cancer Cells, Triggering Apoptotic Cell Demise Investigating the Effects of Dorema hyrcanum Root Extracts on Selective Induction of Programmed Cell Death in Glioblastoma, Ovarian Cancer and Breast Cancer Cell Lines In-vitro study of cytotoxic and apoptotic potential of Thalassia hemprichii (Ehren.) Asch. And Enhalus acoroides (L.f.) Royle against human breast cancer cell line (MCF-7) with correlation to their chemical profile In-vitro study of cytotoxic and apoptotic potential of Thalassia hemprichii (Ehren.) Asch. And Enhalus acoroides (L.f.) Royle against human breast cancer cell line (MCF-7) with correlation to their chemical profile A Dual-Responsive Morphologically-Adaptable Nanoplatform for Targeted Delivery of Activatable Photosensitizers in Precision Photodynamic Therapy Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma model ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway Anticancer properties of red beetroot hydro-alcoholic extract and its main constituent; betanin on colorectal cancer cell lines GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma Prospects of earthworm coelomic fluid as a potential therapeutic agent to treat cancer Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model FDA-approved disulfiram as a novel treatment for aggressive leukemia Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8+ T cell infiltration in melanoma Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts Metallothionein Family Proteins as Regulators of Zinc Ions Synergistically Enhance the Anticancer Effect of Cannabidiol in Human Colorectal Cancer Cells Effects of Lomerizine and Its Metabolite on Glioblastoma Cells Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells Engineering Dual-Responsive Prodrug-Mofs as Immunogenic Cell Death Initiator for Enhancing Cancer Immunotherapy Metabolic diversity of tumor-infiltrating T cells as target for anti-immune therapeutics Recent advances in lung cancer research: unravelling the future of treatment Softening the tumor matrix through cholesterol depletion breaks the physical barrier for enhanced antitumor therapy Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade Targeted Suicide Gene Therapy with Retroviral Replicating Vectors for Experimental Canine Cancers Novel Tetracyclic Azaphenothiazines with the Quinoline Ring as New Anticancer and Antibacterial Derivatives of Chlorpromazine Disulfiram: A novel repurposed drug for cancer therapy Targeting Methionine Addiction of Cancer Cells with Methioninase Mesenchymal stem cells as therapeutic vehicles for glioma Synergistic effect of photothermal and magnetic hyperthermia for in situ activation of Fenton reaction in tumor microenvironment for chemodynamic therapy BCKDK Modification Enhances the Anticancer Efficacy of CAR-T Cells by Reprogramming Branched Chain Amino Acid Metabolism The regulation of amino acid metabolism in tumor cell death: from the perspective of physiological functions Sertaconazole-repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery Protective Effect of Boric Acid Against Ochratoxin A-Induced Toxic Effects in Human Embryonal Kidney Cells (HEK293): A Study on Cytotoxic, Genotoxic, Oxidative, and Apoptotic Effects Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration New Rare Triterpene Glycosides from Pacific Sun Star, Solaster pacificus, and Their Anticancer Activity A review of the clinical progress on helminths and their derivative products in autoimmune disease Subpopulation commensalism promotes Rac1-dependent invasion of single cells via laminin-332 The patient's perspective on radiation for rectal cancer: Initial expectations versus actual experience Radiation therapy for Triple-Negative breast cancer: from molecular insights to clinical perspectives Pacidusin B isolated from Phyllanthus acidus triggers ferroptotic cell death in HT1080 cells Protective effects of silymarin in glioblastoma cancer cells through redox system regulation Raman-AFM-fluorescence-guided impact of linoleic and eicosapentaenoic acids on subcellular structure and chemical composition of normal and cancer human colon cells Gamma Delta T Cells: Role in Immunotherapy of Hepatocellular Carcinoma Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance Dendritic cells resist to disulfiram-induced cytotoxicity, but reduced interleukin-12/23(p40) production The potential of methioninase for cancer treatment The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of C-MYC Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice Induction of the DNA-Repair Gene POLQ only in BRCA1-mutant Breast-Cancer Cells by Methionine Restriction Autophagy Inhibition via Hydroxychloroquine or 3-Methyladenine Enhances Chemotherapy-Induced Apoptosis in Neuro-Blastoma and Glioblastoma Alphaviruses in cancer immunotherapy Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast Tissue Tissue-preserving treatment with non-invasive physical plasma of cervical intraepithelial neoplasia-a prospective controlled clinical trial Fast Track Adaptation of Oncolytic Coxsackie B3 Virus to Resistant Colorectal Cancer Cells - a Method to Personalize Virotherapy Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatment Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients Ferroptosis inhibitors reduce celastrol toxicity and preserve its insulin sensitizing effects in insulin resistant HepG2 cells Hermite-scan imaging for differentiating glioblastoma from normal brain: Simulations and ex vivo studies for applications in intra-operative tumor identificationa)